An Evaluation of Hip Preservation Outcomes
A Comparison of Total Hip Arthroplasty and Hip Preservation Outcomes
1 other identifier
observational
10,000
1 country
1
Brief Summary
The purpose of this study is to assess outcomes of hip preservation surgeries including open and arthroscopic treatment of femoroacetabular impingement (FAI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 16, 2023
CompletedFirst Posted
Study publicly available on registry
February 27, 2023
CompletedStudy Start
First participant enrolled
June 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2053
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2053
April 29, 2025
April 1, 2025
30 years
February 16, 2023
April 24, 2025
Conditions
Outcome Measures
Primary Outcomes (7)
Change in Hip Outcome Score (iHOT-12)
iHOT-12 is a 12-item questionnaire scored using a visual analog scale from 0 to 100, with a score of 100 being the best function and least amount of symptoms, and the overall mean equates to the final iHOT score.
Baseline, 3 months post-operatively, 6 months post-operatively, 1 year post-operatively, 2 years post-operatively, 5 years post-operatively, and 10 years post-operatively
Change in Hip Outcome Score (HOS)
The HOS is a self-administered questionnaire with a scoring system composed of 2 sub-scales. The 19 item Activities of Daily Living (ADL) sub-scale and a 9 item Sports sub-scale. Both have a range of scores from 0 to 4, with 0 being 'unable to do' and 4, 'no difficulty'. N/A is also an option. The total score for each is multiplied by 4 with the highest potential ADL score bing no greater than 68 and the sports scale with the highest potential score being 36. An overall higher score from both sub-scales indicates a greater level of function.
Baseline, 3 months post-operatively, 6 months post-operatively, 1 year post-operatively, 2 years post-operatively, 5 years post-operatively, and 10 years post-operatively
Change in PROMIS questionnaire Score
PROMIS Physical function is a standardized computer adapted test which is able to quickly and effectively score patients on a scale of 0 (not able to function) to 100 (fully functional) based on their physical function. 100 would be a perfect score and 0 would be the worst possible score. Higher scores indicate better physical function.
Baseline, 3 months post-operatively, 6 months post-operatively, 1 year post-operatively, 2 years post-operatively, 5 years post-operatively, and 10 years post-operatively
Change in Sports Survey Score
The Chicago sports score asks athletes questions pertaining to their ability to return to sport. If they are able to return to sport it asks questions about their ability level since returning. Similarly, if they are not able to return to sport it asks questions regarding what has held them back. It is on a 100 point scale with 100 being the best possible outcome and 0 the lowest possible score. Higher scores indicate better ability to return to sports.
Baseline, 3 months post-operatively, 6 months post-operatively, 1 year post-operatively, 2 years post-operatively, 5 years post-operatively, and 10 years post-operatively
Change in Pain Score using a visual analog scale (VAS)
Participants will be asked to estimate their pain on a VAS from 0 to 10, where 0 is considered to be no pain at all and 10 is considered to be the worst possible pain.
Baseline, 3 months post-operatively, 6 months post-operatively, 1 year post-operatively, 2 years post-operatively, 5 years post-operatively, and 10 years post-operatively
Change in PROMIS Pain Interference
Participants will receive the PROMIS pain interference, physical function, and global health modules to assess quality of life, a commonly used general health quality of life assessment tool. PROMIS pain interference is a standardized computer adapted test which is able to quickly and effectively score patients on a scale of 0-100 based on how pain affects their day to day life. 100 would be a perfect score and 0 would be the worst possible score. Higher scores indicate less pain interference on quality of life.
Baseline, 3 months post-operatively, 6 months post-operatively, 1 year post-operatively, 2 years post-operatively, 5 years post-operatively, and 10 years post-operatively
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Global-10
The PROMIS Global-10 is a 10-item patient-reported questionnaire that measures changes in general health in which the response options are presented as 5-point scale, 5 (without any difficulty) to 1 (Unable to do). Higher scores indicate a healthier patient.
Baseline, 3 months post-operatively, 6 months post-operatively, 1 year post-operatively, 2 years post-operatively, 5 years post-operatively, and 10 years post-operatively
Secondary Outcomes (2)
Change in Patients Satisfaction Post Surgery
3 months, 6 months, 1 year, 2 year, 5 year and 10 year
Psychometric thresholds of success will be assessed using anchor questions
up to 10 years
Study Arms (1)
Participants Undergoing Hip Preservation/Surgical Interventions
Data will be prospectively collected on participants undergoing hip preservation at Yale-New Haven Hospital.
Interventions
Hip Preservation surgeries
Eligibility Criteria
Patients age 12 years and older who are candidates for surgical intervention of the hip.
You may qualify if:
- Candidates for surgical intervention of the hip
- Participant and/or guardian has given informed consent and assent as applicable.
You may not qualify if:
- Documented history of pre-existing hip conditions (SCFE, LCPD, acetabular fractures)
- Has language or cognitive barriers preventing understanding of study and consent and assent documents
- Prior revision surgeries
- Patients from the trauma/emergency department
- Individuals with Unusable x-rays
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- Arthrex, Inc.collaborator
Study Sites (1)
Yale New Haven Health
New Haven, Connecticut, 06520, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew Jimenez, MD
Yale University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 16, 2023
First Posted
February 27, 2023
Study Start
June 2, 2023
Primary Completion (Estimated)
June 1, 2053
Study Completion (Estimated)
June 1, 2053
Last Updated
April 29, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- Beginning 12 months and ending 36 months following primary publication.
- Access Criteria
- Proposals should be directed to andrew.jimenez@yale.edu. To gain access, data requestors may need to sign a data use access/use agreement and have approval from an institutional review board/ethics board for the proposed use of such data.
Participant outcomes and demographic data will be shared with other researchers for the purpose of collaboration.